See the Difference: Clinical Implications of BRAFV600E-mutant Metastatic CRC

Session Chair(s)

• 

  Josep Tabernero, MD

  Vall d’Hebron University Hospital
  Barcelona, Spain

Supported by Pierre Fabre

Presentations:

• 13:40 – 13:45

  Welcome and Introduction
  

  Session Chair: Josep Tabernero, MD – Vall d’Hebron University Hospital
• 13:45 – 13:55

  One Size Does Not Fit All | Understanding the Difference
  

  Session Speaker: Josep Tabernero, MD – Vall d’Hebron University Hospital
• 13:55 – 15:05

  Clinical Conversations | Case-based Discussions to Optimise the Management of BRAFV600E-mutant metastic CRC
  

  Session Moderator: Josep Tabernero, MD – Vall d’Hebron University Hospital

  Session Panelist: Chiara Cremolini, MD PhD – Università di Pisa

  Session Panelist: Sebastian Stintzing

  Session Panelist: Julien Taieb – Hôpital Euopéen Georges-Pompidou
• 15:05 – 15:10

  Closing
  

  Session Chair: Josep Tabernero, MD – Vall d’Hebron University Hospital